22 August 2019
ViiV results positive for every 2 month injection…
Final Results
AstraZeneca agrees to buy US FDA Priority Review Voucher from Sobi…
21 August 2019
Half-year Report
Share Buy-Back Programme
Update on the Phase III NEPTUNE trial of Imfinzi plus tremelimumab in Stage IV non-small cell lung cancer…
Appointment of Chief Financial Officer…
20 August 2019
Farxiga met primary endpoint in landmark Phase III DAPA-HF trial for the treatment of patients with heart failure …